Published in Law and Health Weekly, January 16th, 2010
In the Q110 Business Environment Ratings table for the 17 countries in the Middle East and Africa (MEA) region, Egypt has retained 9th position in the matrix above Morocco and Iran, but below Jordan and Oman. Key drawbacks of the Egyptian pharmaceuticals and healthcare market include low per-capita spending on drugs, as well as poor drug pricing and reimbursement conditions. Public sector health expenditure reached a value of EGP19.2bn (US$3.5bn) in 2008, accounting...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.